Cargando…
Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study
BACKGROUND: We examined the feasibility and efficacy of using a non-mydriatic camera to screen for diabetic retinopathy (DR) among youth with type 1 or type 2 diabetes seen in a pediatric endocrinology clinic serving Alabama, the state that has the highest diabetes rate in the United States. METHODS...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487844/ https://www.ncbi.nlm.nih.gov/pubmed/26136849 http://dx.doi.org/10.1186/s13098-015-0054-z |
_version_ | 1782379050374791168 |
---|---|
author | Tapley, Jeffrey L. McGwin, Gerald Ashraf, Ambika P. MacLennan, Paul A. Callahan, Koula Searcey, Karen Witherspoon, C. Douglas Saaddine, Jinan Owsley, Cynthia |
author_facet | Tapley, Jeffrey L. McGwin, Gerald Ashraf, Ambika P. MacLennan, Paul A. Callahan, Koula Searcey, Karen Witherspoon, C. Douglas Saaddine, Jinan Owsley, Cynthia |
author_sort | Tapley, Jeffrey L. |
collection | PubMed |
description | BACKGROUND: We examined the feasibility and efficacy of using a non-mydriatic camera to screen for diabetic retinopathy (DR) among youth with type 1 or type 2 diabetes seen in a pediatric endocrinology clinic serving Alabama, the state that has the highest diabetes rate in the United States. METHODS: 236 youths with type 1 or type 2 diabetes were screened for DR using a non-mydriatic camera. Visual acuity was also assessed. A questionnaire asked parents about diabetes and eye care history. RESULTS: Mean duration since diabetes diagnosis was 5.5 years. 66 % reported receiving an eye examination within the previous year. 97.5 % had images that were gradable. DR was detected in 3.8 % of participants. 9.1 % were visually impaired. CONCLUSIONS: Use of a non-mydriatic fundus camera is feasible and efficacious for DR screening in youth with diabetes. DR screening at routine endocrinology visits may be beneficial in managing youth with diabetes and preventing irreversible vision loss, particularly for those in regions where diabetes rates are high. |
format | Online Article Text |
id | pubmed-4487844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44878442015-07-02 Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study Tapley, Jeffrey L. McGwin, Gerald Ashraf, Ambika P. MacLennan, Paul A. Callahan, Koula Searcey, Karen Witherspoon, C. Douglas Saaddine, Jinan Owsley, Cynthia Diabetol Metab Syndr Research BACKGROUND: We examined the feasibility and efficacy of using a non-mydriatic camera to screen for diabetic retinopathy (DR) among youth with type 1 or type 2 diabetes seen in a pediatric endocrinology clinic serving Alabama, the state that has the highest diabetes rate in the United States. METHODS: 236 youths with type 1 or type 2 diabetes were screened for DR using a non-mydriatic camera. Visual acuity was also assessed. A questionnaire asked parents about diabetes and eye care history. RESULTS: Mean duration since diabetes diagnosis was 5.5 years. 66 % reported receiving an eye examination within the previous year. 97.5 % had images that were gradable. DR was detected in 3.8 % of participants. 9.1 % were visually impaired. CONCLUSIONS: Use of a non-mydriatic fundus camera is feasible and efficacious for DR screening in youth with diabetes. DR screening at routine endocrinology visits may be beneficial in managing youth with diabetes and preventing irreversible vision loss, particularly for those in regions where diabetes rates are high. BioMed Central 2015-06-24 /pmc/articles/PMC4487844/ /pubmed/26136849 http://dx.doi.org/10.1186/s13098-015-0054-z Text en © Tapley et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Tapley, Jeffrey L. McGwin, Gerald Ashraf, Ambika P. MacLennan, Paul A. Callahan, Koula Searcey, Karen Witherspoon, C. Douglas Saaddine, Jinan Owsley, Cynthia Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study |
title | Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study |
title_full | Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study |
title_fullStr | Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study |
title_full_unstemmed | Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study |
title_short | Feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study |
title_sort | feasibility and efficacy of diabetic retinopathy screening among youth with diabetes in a pediatric endocrinology clinic: a cross-sectional study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487844/ https://www.ncbi.nlm.nih.gov/pubmed/26136849 http://dx.doi.org/10.1186/s13098-015-0054-z |
work_keys_str_mv | AT tapleyjeffreyl feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy AT mcgwingerald feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy AT ashrafambikap feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy AT maclennanpaula feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy AT callahankoula feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy AT searceykaren feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy AT witherspooncdouglas feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy AT saaddinejinan feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy AT owsleycynthia feasibilityandefficacyofdiabeticretinopathyscreeningamongyouthwithdiabetesinapediatricendocrinologyclinicacrosssectionalstudy |